Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation
Methylnaltrexone Versus Naloxegol in the Treatment of Opioid-Induced Constipation in the Emergency Department
Sponsor: University of Missouri-Columbia
Listed as NCT03523520, this PHASE4 trial focuses on Constipation Drug Induced and remains completed. Sponsored by University of Missouri-Columbia, it has been updated 12 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
May 2023 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Apr 2022 — May 2023 [monthly]
Recruiting PHASE4
▶ Show 7 earlier versions
-
Mar 2021 — Apr 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
-
Oct 2019 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
-
May 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2019 — May 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Missouri-Columbia
For direct contact, visit the study record on ClinicalTrials.gov .